Recent Finacing
Recent Raise
Arteaus develops an antibody targeting CGRP for migraine prevention, uses a virtual development model with Eli Lilly’s Chorus, and is advancing from Phase 1 to multi-dose and Phase 2.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors